Genotype-guided antiplatelet treatment benefit patients with acute coronary syndrome

Genotype-guided antiplatelet treatment benefit patients with acute coronary syndrome

2019.06.24

Personalized medicine with antiplatelet treatment could decrease the risks of high on-treatment platelet reactivity (HTPR), all-cause mortality, myocardial infarction (MI) and stent thrombosis (ST)...

Mean platelet volume is associated with risk for adverse clinical outcomes in patients with chest pain discharged from hospitals

Mean platelet volume is associated with risk for adverse clinical outcomes in patients with chest pain discharged from hospitals

2019.06.17

A high mean platelet volume (MPV) is associated with risk for adverse clinical outcomes in patients with chest pain when discharged following acute coronary syndrome (ACS) rule-out.The study followed...

Early invasive strategy associated with lower incidence of major adverse cardiovascular events

Early invasive strategy associated with lower incidence of major adverse cardiovascular events

2019.06.10

A meta-analysis has shown that among patients with non-ST-elevation acute coronary syndrome (NSTE-ACS), an early invasive strategy was associated with lower incidence of major adverse cardiovascular...

Premature ticagrelor discontinuation associated with adverse effects in secondary prevention of atherosclerotic CVD

Premature ticagrelor discontinuation associated with adverse effects in secondary prevention of atherosclerotic CVD

2019.06.03

Adverse effects such as bleeding and dyspnea are associated with premature ticagrelor discontinuation in patients with acute coronary syndrome and after percutaneous coronary intervention. In a...

Updated ACS recommendations for Asian patients using extended dual antiplatelet therapy

Updated ACS recommendations for Asian patients using extended dual antiplatelet therapy

2019.05.27

A group of Hong Kong cardiologists has developed specific expert recommendations for Asian patients with acute coronary syndrome (ACS) using extended dual antiplatelet therapy (DAPT). The consensus...

HCV infection increases long-term mortality risk in patients with acute myocardial infarction

HCV infection increases long-term mortality risk in patients with acute myocardial infarction

2019.01.10

A study from Taiwan, presented at the Asian Pacific Society of Cardiology (APSC) Congress 2018, reported that chronic infection with hepatitis C virus (HCV) negatively affects the 12-year mortality...

Circulating amyloid-β predicts mortality and improves risk stratification in patients with NSTEMI

Circulating amyloid-β predicts mortality and improves risk stratification in patients with NSTEMI

2019.01.10

A retrospective cohort study was conducted to determine the prognostic value of baseline circulating levels of amyloid-β (1-40) (Aβ40) after adjustment for the Global Registry of Acute Coronary...

Early escalation of P2Y<sub>12</sub> inhibitors after primary PCI: Insights from the RENOVAMI Registry

Early escalation of P2Y12 inhibitors after primary PCI: Insights from the RENOVAMI Registry

2019.01.10

Data from a prospective observational registry (RENOVAMI) in 1,057 consecutive patients in an Italian hub-and-spoke network have revealed insights on early escalation to new-generation P2Y12...